+ Watch AMGN
on My Watchlist
A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.
I sold my Amgen just before the new, strict Medicare guidelines came through on the use of Aranesp to treat chemotherapy-induced anemia.I work in a cancer clinic, and we are very concerned that many of our patients are denied this important drug until their hematocrits are spriralling down towards critically low. Medicare cites potential risks, but we know it's all about $$.I like Amgen though, and would like to revise this pick once they overcome the layoffs and if they can recoup the lost profits from the Medicare reimbursement fiasco.
and now in 2010 what are you views?thankyou!
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions